July 3, 2020 / 12:26 AM / a month ago

BRIEF-Beigene Says Began Commercializing Xgeva (Denosumab) In China

July 3 (Reuters) - Beigene Ltd:

* ON JUNE 30, CO BEGAN COMMERCIALIZING XGEVA (DENOSUMAB) IN CHINA FOR TREATMENT OF GIANT CELL TUMOR OF BONE Source text bit.ly/2ZpQivq Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below